SAM #36E79726R0037

VA Solicitation for Prednisolone Acetate 1% Ophthalmic Suspension Bottles

The Department of Veterans Affairs (VA) is seeking suppliers for Prednisolone Acetate 1% Ophthalmic Suspension to support multiple federal healthcare agencies. - Government Buyer: - Department of Veterans Affairs (VA), Enterprise Procurement Office / NAC Pharmaceuticals - Also serving Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), Federal Health Care Center (FHCC), and State Veterans Homes - Products Requested: - Prednisolone Acetate 1% Ophthalmic Suspension - 5 mL bottle: 392,107 units annually - 10 mL bottle: 70,070 units annually - 15 mL bottle: 10,172 units annually - Requirements: - Each product must have a unique National Drug Code (NDC) number - Offeror’s label must be the only label on the bottle - Bottles must accommodate a label of specific dimensions for barcode and expiration date visibility - Distribution through VA and DoD Pharmaceutical Prime Vendor Programs - Contract Structure: - One-year base period with four one-year option periods (up to five years total) - OEMs and Vendors: - No specific OEMs named; eligible manufacturers are those producing Prednisolone Acetate 1% Ophthalmic Suspension meeting federal requirements - Notable Requirements: - Strict labeling and packaging specifications - Product must be suitable for federal mail order and institutional pharmacy distribution

Description

Presolicitation Notice

Page 1 of 4 Presolicitation Notice *=Required Field Presolicitation Notice

Page 1 of 2 PRE-SOLICITATION NOTICE:  The VA Enterprise Procurement Office intends to issue Request for Proposal (RFP) 36E79726R0037 for an unrestricted procurement for Prednisolone Acetate 1% Ophthalmic Suspension, for the Department of Veterans Affairs (VA) (inclusive of Consolidated Mail Order Pharmacies (CMOPs) and Option 2 State Veterans Homes (SVH)), Department of Defense (DoD) (inclusive of Tricare Mail Order Pharmacies (TMOPs)), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). 

VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs. One or more of the items under this acquisition is subject to the World Trade Organization Government Procurement Agreement and Free Trade Agreements. 

Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC number that is unique to the offeror. The successful offeror/contractor's label with its unique NDC shall be the only label on the product. Contractors shall not affix their label over another label on the product. VA labels must be able to securely adhere on top of the successful offeror/contractor s label.  The bottle must fit a label with a dimension of 5.25 x 2 . The 0.5  additional space is required to keep the bar code exposed and/or allow for the display of the expiration date and lot number. Solicitation # 36E79726R0037 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about October 01, 2026, with a tentative closing date of October 15, 2026. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check Contracting Opportunities at SAM.gov for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Michael Olszewski. Questions can be e-mailed to Michael.Olszewski@va.gov.  

The estimated annual requirements are as follows: 

The estimated annual requirements are as follows:

ITEM

DESCRIPTION PACKAGE SIZE (ML) TOTAL ESTIMATED ANNUAL USAGE (Bottles) 1 PREDNISOLONE ACETATE 1% SUSP,OPH 5 392,107 2 PREDNISOLONE ACETATE 1% SUSP,OPH 10 70,070 3 PREDNISOLONE ACETATE 1% SUSP,OPH 15 10,172

View original listing